Navigation Links
Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Date:6/6/2008

HANOI, Vietnam, June 6 /PRNewswire-FirstCall/ -- QIAGEN was featured this week for its efforts to eliminate cervical cancer at the 14th annual Global Summit of Women in Hanoi, Vietnam. CEO Peer Schatz came to this prominent international platform to issue a call to other leaders in business, NGOs and governments to join him and campaign to create a cervical-cancer-free world.

"Nearly 500,000 women around the world are diagnosed with cervical cancer every year - a shocking number considering that it's a highly preventable disease," Mr. Schatz told ministers from more than 60 countries at a roundtable on the opening day. "However, QIAGEN and partners such as the summit's Global Consortium of Women to End Cervical Cancer are showing that where there is a will there is a way. I urge you to join us. The tools are there; they just need desire and commitment to put them to work."

The Global Summit of Women annually brings together more than 1,000 senior-level women in business, government and advocacy, and is often called the "Davos for Women." It celebrates women's leadership by bringing together business and governmental professionals to work together to improve the economic power and well-being of females throughout the world. At last year's summit, President Irene Natividad announced the launch of an international "consortium to end cervical cancer." The consortium "aims to educate women about cervical cancer prevention and encouraging governments to provide easy access to the latest methods of prevention and detection, including HPV testing and vaccination." Human papillomavirus (HPV) is the primary cause of cervical cancer, and QIAGEN has developed the only FDA- and EU-approved test for high-risk types of the virus.

"We are delighted to have corporate leaders such as QIAGEN partner with us. Together we can leave the legacy of a cervical-cancer-free world to the next generations of women," said Ms Natividad. "We have made huge strides with
'/>"/>

SOURCE QIAGEN NV
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
3. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
4. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
5. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
6. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
7. New Study Shows Listeria Vaccine for Cervical Cancer Found Safe
8. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
9. GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
10. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
11. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/--TheFDAgrantedtraditionalapprovalforINTELENCE&...nscriptaseinhibitor(NNRTI).INTELENCEistheonlyNNRTI...adultswhoareexperiencingvirologicfailurewithHIV-1s...)agents.Thetraditionalapprovalisbasedon48-weekdata...CEiscurrentlymarketedintheU.S.byTibotecTherapeutic...
(Date:11/25/2009)...ire/--RegadoBiosciences,aprivatelyheldcompanyleadi...controlagents,announcedthatDavidMazzo,PhD,CEOandPr...lHealthCareConferenceattheNewYorkPalaceHotelinNewY...EST)onTuesday,December1andwillincludeanoverviewoft...tprogram,theanticoagulantsystem,REG1.Thehealthcare...
(Date:11/25/2009)...re-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedical...ysissystems,announcedtodaythatClintSeverson,chairm...ualPiperJaffrayHealthCareConferenceonWednesday,Dec...heNewYorkPalaceHotelinNewYorkCity. ,, AboutAba...rtablebloodanalysissystemsforuseinanyveterinaryorh...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Identafi 28TM 29 3000 Picked by Dentistry Today Magazine as One of the Top 100 Products of 2009 50599 1Identafi 28TM 29 3000 Picked by Dentistry Today Magazine as One of the Top 100 Products of 2009 50599 2Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 1Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 2Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 3Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 4Growth Hormone May Build Muscle in Older Men 50591 1Growth Hormone May Build Muscle in Older Men 50591 2
...arch 11 InteKrin Therapeutics, Inc., a clinical s..., metabolism and obesity, today announced it has c...y of INT131, a novel, non-TZD selective modulator ... diabetes (T2DM). INT131-007 is a 24 week, high d...controlled study of INT131 at four doses in poorly...
...h 10 BioSpecifics Technologies Corp. (Nasdaq: B...t in class collagenase-based products, today annou...l present a corporate overview at the upcoming Cow...on Tuesday, March 17, 2009, at 9:30am ET at the Bo...ebcast of the presentation can be accessed at www...
Other Medicine Technology:InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2
(Date:11/25/2009)...ncer who were treated with cisplatin-based chemoth...ological side effects and Raynaud-like phenomena, ...ccording to a new study published online November ...e . , Marianne Brydy, M.D., of the Department of...n, Norway, and colleagues conducted a cross-sectio...
(Date:11/25/2009)...rt to draw definite conclusions, experts say, , ...In diabetic patients with blocked coronary arterie...t one year whether patients undergo bypass surgery... report. , Bypass surgery has been the standard...ery disease. However, less invasive approaches suc...
(Date:11/25/2009)...l symptoms, study finds , , WEDNESDAY, ...cts are among the potential problems faced by long...ted with cisplatin-based chemotherapy, a new study...n men treated for unilateral testicular cancer bet...rvey conducted from 1998 to 2002. , The researc...
(Date:11/25/2009)...4thStraightYear ,, WASHINGTON,Nov.25/PRNewswi...(LCA-GA)issuedthe 4thAnnualReportCardonLungCancer ...tthislethaldiseaseinthestateofGeorgia.LCA-GAisacha...izationdedicatedexclusivelytopatientsupportandadvo..., (Logo: http://www.newscom.com/cgi-bin/prnh/20081...
(Date:11/25/2009)...ill tumor cells, study finds , , WEDNESD...elivered in a fingernail-size implant eliminated m...The method uses polymer disks, 8.5 millimeters in ...gens and implanted under the skin to reprogram the...rsity scientists who developed the implant predict...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...he young and fair skinned tan lovers should give s...ce the development of skin cancer, the European Co...ve arm of the European Union said that its scienti...in cancer. European Commission spokesman Greg...
...latant and unwholesome food marketing is on the ri...obesity. It is evident that food marketing impacts...tary pattern and food habits that can last a lifet...food advertisements on dietary choice. They have p...
...olice today, had seized a large quantity of spurio...n for possession of drugs having fake labels of co...p-off, a police team raided a drug store in Leader...whose genuine versions would have been worth Rs 15...
...anofi Pasteur, the world's third-largest pharmaceu...y have reached an initial agreement to conduct joi...used on humans early next year.// According to...ths to 18 years owing to the increased susceptibil...
...he U.S. Food and Drug Administration has approved ...ment for multiple myeloma, which is a type of bloo...rug will now be able to market Revlimid for use in...earlier been treated with chemotherapy. The ...
...he central government Thursday assured the Delhi H...te of Medical Sciences (AIIMS) director P. Venugop...etition. Additional Solicitor General Gopal S...ng upon the AIIMS governing body's recommendation ...
Other Medicine News:Health News:Agreement for Joint Trials of Avian Flu Vac cine on Humans 2Health News:Venugopal will not be Sacked Before Court Verdict: Central Government 2
Neumann Tying Forceps - Straight
Neumann Tying Forceps - Angled
Shepard Straight Tying Forceps
Shepard Curved Tying Forceps
Medicine Products: